European Commodity Winners This Week IBEX 35 Mini (May 2025) (EZK25), +6% About 25% of the index is represented by European ...

Q1 2025 Management View CEO Chris Boerner highlighted a strong start to 2025 with $11.2 billion in total revenue, driven by ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

Biotech stock Scholar Rock ( SRRK 2.97%) was popular among investors on Wednesday after a positive new analyst note on the company made the rounds. This resulted in the stock bumping nearly 3% higher ...

AB Science SA (Euronext - FR0010557264 - AB) announces today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) granted orphan drug status to AB8939 for the ...

Short Summary The EU, UK, and USA each have distinct and evolving regulatory systems for medicines and medical devices, involving strict approval, surveillance, and market access requirements managed ...

According to the daily chart, the bearish sentiment of USD/CHF prevails as the pair is below the key 100-day Exponential ...

PMIs may slip below 50, raising policy doubts. USD/JPY could climb if weak data and dovish BoJ tone outweigh risk-off flows.

A group of expert neurologists have expressed concerns at the European Commission’s (EC) decision to formally approve the Alzheimer’s drug lecanemab (Leqembi) despite uncertain benefits. Lecanemab, ...

DAX opens lower as gold hits $3,499. Traders watch ECB rate cut bets and Fed forecast for clues on near-term DAX outlook amid ...